. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: J Neuroimmune Pharmacol. 2021 Sep 15;16(4):796–805. doi: 10.1007/s11481-021-10011-w
Under no circumstances may this AM be shared or distributed under a Creative Commons or other form of open access license, nor may it be reformatted or enhanced, whether by the Author or third parties. See here for Springer Nature’s terms of use for AM versions of subscription articles: https://www.springernature.com/gp/open-research/policies/accepted-manuscript-terms